Hoth Therapeutics Inc (HOTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,691 | 283 | 1,230 | N/A | N/A |
| Marketable Securities | 804 | N/A | N/A | N/A | N/A |
| Other current assets | 30 | 207 | 0 | 0 | 0 |
| TOTAL | $2,635 | $502 | $1,230 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 1 | 2 | 4 | N/A | N/A |
| Other Non-Current Assets | 200 | 0 | 0 | 0 | 0 |
| TOTAL | $201 | $2 | $4 | $N/A | $N/A |
| Total Assets | $2,836 | $504 | $1,234 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 404 | 142 | 48 | 0 | 0 |
| Accrued Expenses | 36 | 207 | 2 | N/A | N/A |
| TOTAL | $440 | $349 | $50 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $440 | $349 | $50 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 405 | 377 | N/A | N/A | N/A |
| Common Shares | 1 | 1 | 1 | N/A | N/A |
| Retained earnings | -12,216 | -4,511 | -2,016 | N/A | N/A |
| TOTAL | $2,396 | $155 | $1,185 | $N/A | $N/A |
| Total Liabilities And Equity | $2,836 | $504 | $1,234 | $0 | $0 |